AzTrials
AzTrials

Young AthletesLYMPH-RECNCT07892105

Effects of Manual Lymphatic Drainage and Pressotherapy on Muscle Recovery After Eccentric Exercise in Physically Active Young Adults

A study testing Manual Lymphatic Drainage and Intermittent Pheumatic Compression in people with Young Athletes, run by Camilo Jose Cela University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial aims to compare the effects of manual lymphatic drainage (MLD), intermittent pneumatic compression (IPC), and passive rest on recovery following exercise-induced muscle damage (EIMD) induced by a Nordic Hamstring Exercise protocol in physically active young adults. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Young Athletes
What is being tested?
Manual Lymphatic Drainage and Intermittent Pheumatic Compression
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
16 Nov 2026to 16 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Aged between 18 and 30 years.
  • Physically active according to the World Health Organization recommendations.
  • Able to understand and follow study procedures.
  • Willing to provide written informed consent.
  • Able to attend all assessment sessions.
  • No lower-limb musculoskeletal injury within the previous 6 months

Who cannot join

  • History of cardiovascular, metabolic, neurological, or neuromuscular disorders.
  • Current musculoskeletal pain or injury affecting the lower limbs.
  • Lower-limb surgery within the previous 6 months.
  • Current use of analgesic, anti-inflammatory, or muscle recovery medications.
  • Participation in vigorous exercise within 24 hours prior to baseline assessment.
  • Receipt of physiotherapy, manual lymphatic drainage, or pressotherapy treatment within the previous month.
  • Contraindications to manual lymphatic drainage or intermittent pneumatic compression.
  • Inability to comply with study procedures.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Edurne Úbeda D'Ocasar, Doctor contact

+34 8153131 ext. 19217

eubeda@ucjc.edu

Edurne Úbeda D'Ocasar, Dcotor contact

+34 8153131 ext. 19217

eubeda@ucjc.edu

About this study

Official title: Effects of Manual Lymphatic Drainage and Pressotherapy Compared With Passive Rest on Recovery Following Eccentric Exercise-Induced Muscle Damage in Physically Active Young Adults: A Randomized Controlled Trial

This randomized controlled trial aims to compare the effects of manual lymphatic drainage (MLD), intermittent pneumatic compression (IPC), and passive rest on recovery following exercise-induced muscle damage (EIMD) induced by a Nordic Hamstring Exercise protocol in physically active young adults.

Participants will be randomly allocated to one of three recovery strategies after completing a standardized eccentric exercise protocol designed to induce muscle damage. Recovery will be assessed through clinical, metabolic, functional, and anthropometric outcomes, including delayed-onset muscle soreness (DOMS), perceived recovery status (PRS), blood lactate concentration, countermovement jump (CMJ) performance, and thigh circumference. Assessments will be conducted at baseline, immediately after exercise, during the acute recovery period, immediately after the assigned intervention, and during follow-up visits at 24 hours, 3 days, and 7 days.

The study aims to provide evidence regarding the effectiveness of manual lymphatic drainage and pressotherapy as post-exercise recovery strategies in physically active young adults.

Read the detailed description

Exercise-induced muscle damage (EIMD) is a common physiological response to strenuous or unaccustomed exercise, particularly when eccentric muscle contractions predominate. EIMD is characterized by delayed-onset muscle soreness, temporary reductions in muscle function and performance, inflammatory responses, and biochemical alterations. Despite representing a normal adaptive process, EIMD may temporarily impair physical performance and recovery.

Manual lymphatic drainage (MLD) and intermittent pneumatic compression (IPC) are widely used passive recovery strategies intended to enhance lymphatic and venous return, facilitate metabolite clearance, and reduce post-exercise discomfort. Although previous studies suggest potential benefits for symptom recovery and lactate clearance, evidence regarding their effectiveness remains inconsistent, particularly in physically active non-athlete populations.

This randomized controlled trial will investigate the comparative effects of manual lymphatic drainage, intermittent pneumatic compression, and passive rest following a standardized Nordic Hamstring Exercise protocol designed to induce exercise-induced muscle damage. Outcome measures will include blood lactate concentration, countermovement jump performance, delayed-onset muscle soreness, perceived recovery status, and thigh circumference.

The findings may help determine whether these passive recovery interventions provide clinically meaningful benefits compared with passive rest and contribute to evidence-based recommendations for post-exercise recovery

Conditions
Young Athletes
Being tested
Manual Lymphatic Drainage, Intermittent Pheumatic Compression
Keywords
Manual Lymphatic drainage, Pressotherapy, Muscle recovery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Manual Lymphatic DrainageOther

    articipants will receive a standardized manual lymphatic drainage session administered by a licensed physiotherapist immediately following the fatigue-inducing protocol. The intervention will be performed according to recognized manual lymphatic drainage techniques, with the aim of facilitating fluid mobilization and enhancing post-exercise recovery.

  • Intermittent Pheumatic CompressionOther

    Participants will receive a session of intermittent pneumatic compression therapy immediately following the exercise-induced fatigue protocol. Treatment will be administered using a pneumatic compression device with sequential inflation and deflation cycles applied to the lower limbs.

Study groups in NCT07892105
Study groupRoleWhat they receive
Manual Lymphatic Drainage (MLD)ExperimentalParticipants will receive a 10-minute session of manual lymphatic drainage according to the Vodder technique following the exercise-induced muscle damage protocol.
Receives: Other: Manual Lymphatic Drainage
Intermittent Pneumatic Compression (Pressotherapy)Active comparatorParticipants will receive a 10-minute session of intermittent pneumatic compression using a four-chamber sequential compression device set at 90 mmHg following the exercise protocol.
Receives: Other: Intermittent Pheumatic Compression
Control groupNo interventionParticipants will remain seated at rest for 10 minutes following the exercise-induced muscle damage protocol without receiving any recovery intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Blood Lactate Concentration

    Blood lactate concentration (mmol/L) measured from capillary blood samples using a portable lactate analyzer. Changes in lactate concentration will be used to assess metabolic recovery following exercise-induced muscle damage.

    Measured: Baseline, immediately post-exercise, 3 minutes post-exercise, 10 minutes post-exercise, and immediately after the recovery intervention

  2. Change in Countermovement Jump Performance

    Countermovement jump (CMJ) height, measured in centimeters using a validated jump assessment system. Changes in jump performance will be used as an indicator of neuromuscular recovery and lower-limb functional capacity.

    Measured: Baseline, immediately post-exercise, immediately after the recovery intervention, 24 hours, 3 days, and 7 days after exercise.

Secondary outcomes (3)
  1. Delayed-Onset Muscle Soreness (DOMS)

    Muscle soreness assessed using a 10-cm Visual Analog Scale (VAS), where 0 indicates no soreness and 10 indicates maximal soreness.

    Measured: Baseline, immediately post-exercise, immediately after the intervention, 24 hours, 3 days, and 7 days after exercise.

  2. Perceived Recovery Status

    Recovery status assessed using the Perceived Recovery Status Scale (PRS), with higher scores indicating a greater subjective perception of recovery.

    Measured: Baseline, immediately post-exercise, immediately after the intervention, 24 hours, 3 days, and 7 days after exercise.

  3. Change in Thigh Circumference

    Thigh circumference (cm) measured at a standardized anatomical location to evaluate potential changes associated with exercise-induced muscle damage and recovery.

    Measured: Baseline, immediately after exercise, immediately after the intervention, 24 hours, 3 days, and 7 days after exercise.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2026
  2. Study start16 Nov 2026 (estimated)
  3. Primary completion26 Feb 2027 (estimated)
  4. Study completion16 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07892105
Sponsor's protocol ID
UCJCDLMPRESO
Acronym
LYMPH-REC
Status last verified
Oct 2026
First submitted
19 Oct 2026
Last updated
23 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Manual Lymphatic Drainage and Intermittent Pheumatic Compression in people with Young Athletes, run by Camilo Jose Cela University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Edurne Úbeda D'Ocasar, Doctor (+34 8153131 ext. 19217, eubeda@ucjc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Blood Lactate Concentration (time frame: Baseline, immediately post-exercise, 3 minutes post-exercise, 10 minutes post-exercise, and immediately after the recovery intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in